Ranbaxy Q1 cons net up 19.91% Rs 153 cr

Ranbaxy Labs has announced its first quarter results. It has posted consolidated net profit of Rs 153 crore as against Rs 127.6 in the same quarter of last year, growth of 19.91%. Net sales went up by 3.78% at Rs 1623.1 crore from Rs 1564 crore.

It has reported net sales of USD 409 million versus USD 355 million and net profit of USD 39 million versus USD 32 million. Forex gains stood at Rs 79.8 crore versus loss of Rs 55.9 croer (YoY).

According to CNBC-TV18 estimates, the company was expected to post net profit of Rs 139 crore on net sales of Rs 1731 crore.

Particulars	Mar-08	Dec-07	Sep-07	Jun-07
Net Sales / Interest Earned / Operating Income	987.286	993.32	1038.12	1014.63
Other Income	87.68	124.79	115.32	73.37
Total Income	1074.966	1118.11	1153.44	1088
Expenditure	-885.169	-1006.81	-883.37	-674.49
Operating Profit	189.797	111.3	270.07	413.51
Interest	-26.246	-24.76	-26.27	-24.79
Profit Before Depreciation and Tax	163.551	86.54	243.8	388.72
Depreciation	-32.149	-30.03	-32.52	-27.71
Profit before Tax	131.402	56.51	211.28	361.01
Tax	-27.98	-8.11	-43.12	-69.86
Profit after Tax	103.422	48.4	168.16	291.15
Extraordinary Items	-	-	-	-
Net Profit	103.422	48.4	168.16	291.15
Equity Capital	186.535	186.54	186.48	186.43